How to trade richly-valued pharma stocks
More and more frontline Pharma stocks are now richly valued thereby not providing enough investment opportunities to investors. However, experts believe the next level of outperformance is likely to come from the likes of Lupin, Cipla and other midcap Pharma stocks. In a bull market move, experts add, these stocks may start to under-perform their high beta peers.
